Arima Fumito
Department of Hematology, Shin-Koga Hospital.
Rinsho Ketsueki. 2023;64(6):461-464. doi: 10.11406/rinketsu.64.461.
Although vaccination against coronavirus infection 2019 (COVID-19) has been found to be effective, reports of adverse reactions continue to appear. We report the development of severe aplastic anemia post BTN162b2 mRNA COVID-19 vaccination in patient undergoing dialysis. The pathogenesis and risk factors for post-vaccination aplastic anemia remain unclear. We must remain vigilant to aplastic anemia following COVID-19 vaccination. The risk of aplastic anemia should be identified, and management methods should be established.
尽管已发现2019冠状病毒病（COVID-19）疫苗有效，但不良反应报告仍不断出现。我们报告了1例接受透析的患者在接种BNT162b2 mRNA COVID-19疫苗后发生严重再生障碍性贫血的情况。接种疫苗后再生障碍性贫血的发病机制和危险因素仍不清楚。我们必须对COVID-19疫苗接种后的再生障碍性贫血保持警惕。应识别再生障碍性贫血的风险，并建立管理方法。
